Apoptosis caused by chemotherapeutic inhibition of nuclear factor-κB activation

Cancer Research

Volumn 63, Issue 2, 2003, Pages 290-295

  Biswas, Debajit K ^a   Martin, Katherine J ^a   McAlister, Cliona ^a   Cruz, Antonio P ^a   Graner, Edgard ^a   Dai, Sun Chun ^a   Pardee, Arthur B ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

12 (2 CYANOETHYL) 6,7,12,13 TETRAHYDRO 13 METHYL 5 OXOINDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; DEATH ASSOCIATED PROTEIN KINASE; DOMINANT NEGATIVE I KAPPA B KINASE MUTANT; EPIDERMAL GROWTH FACTOR; FACTOR 4 1BB; FACTOR OX40; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF APOPTOSIS 1; INHIBITOR OF APOPTOSIS PROTEIN; PROTEIN KINASE; PROTEIN KINASE C INHIBITOR; PROTEIN P21; PROTEIN P53; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; UNCLASSIFIED DRUG; X INHIBITOR OF APOPTOSIS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER INHIBITION; CANCER REGRESSION; CONTROLLED STUDY; DNA BINDING; DNA MICROARRAY; DOWN REGULATION; DRUG EFFECT; DRUG EFFICACY; GENE EXPRESSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL CULTURE; UPREGULATION;

ADENOCARCINOMA; ANIMALS; APOPTOSIS; CARBAZOLES; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; I-KAPPA B KINASE; INDOLES; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED A; MUTATION; NF-KAPPA B; PROTEIN-SERINE-THREONINE KINASES; TUMOR CELLS, CULTURED;

EID: 0037439685     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Biswas, D. K., Cruz, A. P., Gansberger, E., and Pardee, A. B. Epidermal growth factor-induced nuclear factor KB activation: a major pathway of cell-cycle progression in estrogen-receptor negative breast cancer cells. Proc. Natl. Acad. Sci. USA, 97: 8542-8547, 2000.
2. Biswas, D. K., Dai, S-C. Cruz, A. P., Weiser, B., Graner, E., and Pardee, A. B. The nuclear factor κB (NF-κB): a potential therapeutic target for estrogen receptor negative breast cancers. Proc. Natl. Acad. Sci. USA, 98: 10386-10391, 2001.
3. Sun, L., and Carpenter, G. Epidermal growth factor activation of NF-κB is mediated through IκBα degradation and intracellular free calcium. Oncogene, 16: 2095-2102, 1998.
4. Galang, C. K., Garcia-Ramirez, J. J., Soloski, P. A., Westwick, J. K., Der, C. J., Neznanov, N. N., Oshima, R. G., and Hauser, C. A. Oncogenic Neu/ErbB-2 increases Ets, AP-1, and NF-κB-dependent gene expression, and inhibiting Ets activation blocks Neu-mediated cellular transformation. J. Biol. Chem., 271: 7992-7998, 1996.
5. Ghosh, S., and Karin, M., Missing pieces in the NF-κB puzzle. Cell, 109: S81-S96, 2002.
6. Karin, M., and Lin, A. NF-κB at the crossroads of life and death. Nat. Immunol., 3: 221-227, 2002.
7. Barkett, M., and Gilmore, T. D. Control of apoptosis by Rel/NF-κB transcription factors. Oncogene, 18: 6910-6924, 1999.
8. Sen, R., and Baltimore, D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell, 46: 705-716, 1986.
9. Grilli, M., Chiu, J. J-S., and Lenardo, M. J. NF-κB and Rel: participants in a multiform transcriptional regulatory system. Int. Rev. Cytol., 141: 1-60, 1993.
10. Pahl, H. L., Activators and target genes of Rel/NF-κB transcription factors. Oncogene, 18: 6853-6866, 1999.
11. Karin, M., Cao, Y., Greten, F. R., and Li., Z-W. NF-κB in cancer: from innocent by stander to major culprit. Nat. Rev., 2: 301-309, 2002.
12. Baldwin, A. S., Jr. The NF-κB and IκB proteins: New discoveries and insights. Ann. Rev. Immunol., 14: 649-683, 1996.
13. 1 to S-phase transition. Mol. Cell. Biol., 19: 2690-2698, 1999.
14. de-Fazzio, A., Chiew, Y. E., McEvoy, M., Watts, C. K., and Sutherland, R. L. Antisense estrogen receptor RNA expression increases epidermal growth factor receptor gene expression in breast cancer cells. Cell Growth Differ., 8: 903-911, 1997.
15. cdc2 phosphorylation of Survivin. Proc. Natl. Acad. Sci. USA, 97: 13103-13107, 2000.
16. Grigorian, M., Ambartsumian, N., Lykkesfeldt, A. E., Bastholm, L., Elling, F., Georgiev, G., and Lukanidin, E. Effect of mts1 (S100A4) expression on the progression of human breast cancer cells. Int. J. Cancer, 67: 831-841, 1996.
17. Scully, R., Ganesan, S., Brown, M., DeCaprio, J. A., Canistra, S. A., Feunteum, J., Schnitt, S., and Livingston, D. M. Location of BRCA1 in human breast and ovarian cancer cells. Science (Wash. DC), 272: 123-126, 1996.
18. Dignam, J. D., Lebovitz, R. M., and Roeder, R. D. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nuceleic Acids Res., 11: 1475-1489, 1983.
19. Romashkova, J. A., and Makarov, S. S. NF-κB is a target of AKT in anti-apoptotic PDGF signaling. Nature (Lond.), 402: 86-90, 1999.
20. Tang, G., Yang, J., Minemoto, Y., and Lin, A. Blocking-caspase-3-mediated proteolysis of Ikkβ suppresses TNFα-induced apoptosis. Mol. Cell, 8: 1005-1016, 2001.
21. Igney, F. H., and Krammer, P. H. Death and anti-death: Tumour resistance to apoptosis. Nature (Lond.), 2: 277-288, 2002.
22. Samuels-lev, Y., O'Connor, D. J., Bamaschi, D., Trigiante, G., Hieh, J-K., Zhon, S., Camprgue, Naumovski, Crook, T., and Lu, X. ASAP proteins specifically stimulate the apoptotic function of p53. Mol. Cell. 8: 781-794, 2001.
23. Weinstein, I. B. Disorders in cell circuitry during multistage carcinogenesis: the role of homeostasis. Carcinogenesis (Lond.), 21: 857-864, 2000.
24. Debnath, J., Millas, K. R., Collins, N. L., Reginato, M. J., Muthuswamy, S. K., and Brugge, J. The role of apoptosis in creating and maintaining luminal space within normal and oncogene-expressing mammary acini. Cell, 111: 29-40, 2002.
25. Keyomarsi, K., and Pardee, A. B. Selective protection of normal proliferating cells against the toxic effects of chemotherapeutic agents. Prog. Cell Cycle Res., 5: in press, 2002.